Initiation and resolution of inflammation are considered to be tightly connected processes. Lipoxins (LX) are proresolution lipid mediators that inhibit phlogistic neutrophil recruitment and promote wound-healing macrophage recruitment in humans via potent and specific signaling through the LXA 4 receptor (ALX). One model of lipoxin biosynthesis involves sequential metabolism of arachidonic acid by two cell types expressing a combined transcellular metabolon. It is currently unclear how lipoxins are efficiently formed from precursors or if they are directly generated after receptor-mediated inflammatory commitment. Here, we provide evidence for a pathway by which lipoxins are generated in macrophages as a consequence of sequential activation of toll-like receptor 4 (TLR4), a receptor for endotoxin, and P2X 7 , a purinergic receptor for extracellular ATP. Initial activation of TLR4 results in accumulation of the cyclooxygenase-2-derived lipoxin precursor 15-hydroxyeicosatetraenoic acid (15-HETE) in esterified form within membrane phospholipids, which can be enhanced by aspirin (ASA) treatment. Subsequent activation of P2X 7 results in efficient hydrolysis of 15-HETE from membrane phospholipids by group IVA cytosolic phospholipase A 2 , and its conversion to bioactive lipoxins by 5-lipoxygenase. Our results demonstrate how a single immune cell can store a proresolving lipid precursor and then release it for bioactive maturation and secretion, conceptually similar to the production and inflammasome-dependent maturation of the proinflammatory IL-1 family cytokines. These findings provide evidence for receptor-specific and combinatorial control of pro-and anti-inflammatory eicosanoid biosynthesis, and potential avenues to modulate inflammatory indices without inhibiting downstream eicosanoid pathways.
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lipidomics | enzyme coupling | membrane remodeling A complex network of danger-sensing receptors and bioactive peptide and lipid signals, including cytokines and eicosanoids, regulates innate immunity. Toll-like receptor (TLR) priming is suggested as a precautionary step in building a significant inflammatory response by driving production of IL-1 family protokines, which remain inactive until a second stimulus drives them to bioactive maturation and secretion (1) . The second step of this process has been most strongly linked to extracellular ATP and specifically to one of its purinergic receptors, P2X 7 (2, 3) , particularly in macrophages (4) .
TLR stimulations also increase prostaglandin synthesis by activating cytosolic phospholipase A 2 (cPLA 2 ) through a Ca 2+ -independent mechanism to release arachidonic acid (AA) from phospholipids, and by increasing expression of cyclooxygenase-2 (COX-2) and microsomal prostaglandin E 2 synthase-1. P2X 7 stimulation activates cPLA 2 through a Ca 2+ -dependent mechanism that couples AA metabolism with 5-lipoxygenase (5-LOX)-activating protein (FLAP), Ca 2+ -activated 5-LOX, and constitutive COX-1 to form leukotrienes (LTs) and prostaglandins (PGs). Short-term (∼1 h) TLR priming of Ca 2+ ionophore/P2X 7 -activated immune cells enhances LT synthesis (5, 6) , but long-term TLR priming (16-18 h) significantly suppresses LT synthesis by different celltype-specific mechanisms (7, 8) .
Whereas PGE 2 , PGI 2 , and LTC 4 promote local edema from postcapillary venules, and LTB 4 amplifies neutrophil recruitment to initiate pathogenic killing, subsequent "class switching" to lipoxin (LX) formation by "reprogrammed" neutrophils inhibits additional neutrophil recruitment during self-resolving inflammatory resolution (9) . The direct link between inflammatory commitment and resolution mediated by eicosanoid signaling in macrophages remains unclear from short-term vs. long-term priming, but the complete temporal changes and important interconnections within the entire eicosadome are now demonstrated.
Results
We first primed immortalized macrophage-like cells (RAW264.7) with the TLR4 agonist Kdo 2 lipid A (KLA) for various times and examined the effects on subsequent purinergic stimulated COX and 5-LOX activity using targeted lipidomic monitoring (Fig. 1A) . Total 5-LOX products (5-HETE, LTC 4 , 11-trans LTC 4 , LTB 4 , 6-trans,12-epi LTB 4 , 6-trans LTB 4 , and 12-epi LTB 4 ) peaked at 2 h and diminished steadily at later time points; total levels from 12 to 24 h were less than 1% of maximal 2-h levels. Total COX products [PGD 2 , PGE 2 , PGF 2α , PGJ 2 , 15-deoxy PGD 2 , 15-deoxy PGJ 2 , 11-hydroxyeicosatetraenoic acid (11-HETE) and 15-HETE] were lowest during short-term TLR4 priming and steadily increased with longer priming durations. AA levels in media were maximal with 2-h priming and were vastly reduced with 8-h priming and beyond (Fig. S1) ; AA release during major COX activity from 2 to 12 h may therefore be slower and/or coupled to COX-2.
The proresolution mediators lipoxin A 4 (LXA 4 ) and 15-epi-LXA 4 were also detected between 4 and 10 h of TLR4 priming and peaked at 8 h (Fig. 1A) . LXA 4 and 15-epi-LXA 4 are trihydroxylated eicosanoids derived from 15(S)-HETE and 15(R)-HETE, respectively. The 15-HETE comprises ∼1-3% COX-2
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1404372111/-/DCSupplemental. metabolism in four different macrophage phenotypes, including RAW cells, after 8 h TLR4 stimulation (10) . Here, lipoxins were formed between 4 and 10 h of TLR4 priming, after the initial phase when COX-2 and 5-LOX products were significantly elevated.
Celecoxib, which specifically inhibits COX-2 formation of PGH 2 , 11-HETE, and 15-HETE, caused a ∼50% decrease in formation of both PGD 2 and lipoxins (Fig. 1B) at 50 nM [near the reported human COX-2 IC 50 of 40 nM (11) and far below the COX-1 IC 50 of 15 μM (11)], thus demonstrating that lipoxin biosynthesis in this system requires COX-2. Additionally, we observed a threefold increase in 5-LOX products vs. without celecoxib after 7.5 h of TLR4 priming (Fig. 1B) , confirming that 5-LOX was still active and competes with COX-2 for AA. In the presence of both 1 μM PGE 2 and 50 nM celecoxib, we observed no inhibition of total 5-LOX metabolism after long-term priming compared with treatment with celecoxib alone (Fig. S2) , which rules out down-regulation of FLAP and reduced 5-LOX activity via PGE 2 -mediated IL-10 signaling that has been observed in dendritic cells (8) . These results were then recapitulated in primary macrophages. Resident peritoneal macrophages (RPMs) express approximately twofold higher constitutive levels of 5-LOX and FLAP vs. RAW cells (Fig. S3 ) and twofold lower levels of COX-2 after TLR4 stimulation (10) . RPMs produced lipoxins with long-term priming ( Fig. S4 A and B) , and increasing cell density increased the level (and concentration) of PGE 2 , but this did not limit lipoxin formation or 5-LOX metabolism of AA based on levels of LTC 4 ( Fig. S4 C and D) . Thus, RPM and RAW macrophages both retain 5-LOX activity in the presence of exogenous or endogenous PGE 2 , unlike in dendritic cells (8) . Ultimately, lipoxins from macrophages likely represent an additional source of the total that might be found in certain physiological environments. Lipoxins can be formed by coordinate conversion of endothelial COX-2/mucosal epithelial 15-LOXderived 15-HETE with neutrophil 5-LOX, or neutrophil 5-LOXderived LTA 4 with platelet 12-LOX, which inhibit neutrophil extravasation (12) . Macrophages initially recruit neutrophils via leukotriene and chemokine signaling in response to TLR signaling and may subsequently switch to forming lipoxins to inhibit neutrophil recruitment in response to high ATP levels.
To assess the enzymatic control of lipoxin formation, chiral chromatography was used to determine the proportions of 15(R)-HETE and 15(S)-HETE in TLR4 primed/purinergic-stimulated RAW cells in the presence and absence of aspirin (ASA). Acetylation of COX-2 by ASA inhibits PG formation and enhances 15(R)-HETE formation (13) . Non-ASA-treated cells produced 15(R)-and 15(S)-HETE at a ratio between 1:3 and 1:4 (R:S) ( Fig. 2A) , and produced both lipoxin epimers at a ratio of ∼1:2 (15-epi-LXA 4 :LXA 4 ). In the presence of ASA, RAW cells produced almost exclusively 15(R)-HETE and 15-epi-LXA 4 . These results demonstrate that COX-2 activity with or without aspirin treatment can lead to formation of 15-epi-LXA 4 , which is more slowly inactivated by 15-hydroxyprostaglandin dehydrogenase (PGDH) than LXA 4 (12) . Lipoxins are well known to be formed by either 12-or 15-LOX activity along with 5-LOX, although the additional contribution by COX-2 may partially explain the observance of delayed resolution caused by COX-2 inhibition or knockout in vivo (14, 15) .
We then assessed the individual contributions of TLR4 and purinergic stimulation to macrophage lipoxin synthesis. LC-MS/ MS chromatograms from incubations with only KLA for 7.5 h or ATP for 30 min contained no detectable peaks coeluting with lipoxins (Fig. 2B) . Four peaks resulted from TLR4 primed, purinergic-stimulated RAW cells, with the third peak coeluting with LXA 4 and 15-epi-LXA 4 . TLR4 primed, purinergic-stimulated cells in the presence of ASA produced exponentially higher levels of four peaks observed in non-ASA-treated cells, and the third peak coeluted with LXA 4 and 15-epi-LXA 4 . ASA treatment partially inhibited COX prostanoids (Fig. S5A ) and proportionally increased the levels of 15-HETE and lipoxins ( Fig. S5 B and C). ASA has previously been shown to specifically increase COX-2-mediated formation of 15(R)-HETE and induce formation of aspirin-triggered lipoxins, including bioactive 15-epi-LXA 4 in cocultures of endothelial cells and neutrophils (16) . This same study also identified a cluster of peaks resembling those shown in Fig. 2B , which corresponded to 15-epi-LXA 4 , 15-epi-11-trans-LXA 4 , and other isomers with different double-bond geometry and C5 and C6 chirality deriving from a 15-epi-5,6-epoxytetraene intermediate (16) . Importantly, low dose (75-81 mg/d) aspirin in humans has since been shown to be anti-inflammatory (17) and cardioprotective (18) via increases in 15-epi-LXA 4 . Our results determined that macrophages require both TLR4 priming and purinergic stimulation to synthesize lipoxins, and ASA exponentially enhances their formation. Consistent with this conclusion, RAW cells produced lipoxins in the presence of exogenous 1 μM 15(R)-HETE and ATP, but not KLA, after 30 min (Fig. 2C) . Also, long-term stimulation with KLA (without adding 15-HETE) led to accumulation of 15-HETE in membrane phospholipids (Fig. 2C) , and the levels in the extracellular medium increased after additional stimulation with ATP (Fig. S5B) . , and total 5-LOX products (as in A) from RAW medium after KLA priming for the indicated times in the absence (white bars) or presence (black bars) of 50 nM celecoxib (∼IC 50 ) followed by stimulation with ATP for the final 30 min; PGD 2 levels were decreased with celecoxib treatment vs. control with 1-h TLR4 priming (*P < 0.01) and 7.5 h TLR4 priming (***P < 0.0001); lipoxin levels were not detected (N.D.) with 1 h priming and were decreased at 7.5 h TLR4 priming with celecoxib treatment vs. control (**P < 0.005); total 5-LOX products with 1-h priming were not significantly different with celecoxib vs. control, and at 7.5-h priming were increased with celecoxib vs. control (***P < 0.0001). Data are mean values of three separate experiments ± SEM.
We then examined specific purinergic receptor requirements for lipoxin synthesis because most P2X and P2Y receptors can be activated by nanomolar ATP concentrations, whereas only P2X 7 requires high micromolar-millimolar concentrations (19) . In murine macrophages, P2X 7 was previously shown to be responsible for the majority of eicosanoids generated with mM ATP (20) . Lipoxin synthesis was confirmed to be dependent on P2X 7 stimulation by varying the concentration of ATP in the presence of 1 μM 15(R)-HETE. PG and LT (Fig. 3A) and AA levels (Fig. S6) increased significantly only with mM ATP vs. midhigh μM ATP; 15-epi-LXA 4 was only detected with mM ATP (Fig. 3A) .
Whereas formation of PG and 15-HETE by COX, and LT and 5-HETE by 5-LOX all require hydrolysis of esterified AA by cPLA 2 , it has generally been assumed that lipoxin production from 15-HETE is independent of cPLA 2 action. However, we found that in the presence of 1 μM 15(R)-HETE and a potent, selective inhibitor of cPLA 2 [without effect on FLAP or 5-LOX (21)], pyrrophenone, ATP-stimulated COX and 5-LOX arachidonate-derived product formation was dose dependently inhibited as expected, and yet 15-epi-LXA 4 was also dose dependently inhibited (Fig. 3B) .
It is known that 15-HETE supplied to neutrophils is rapidly esterified into membrane phosphatidylinositol (PI), phosphatidylcholine (PC), and other phospholipids and neutral lipids within 15 s to 20 min (22) . Subsequent activation with the Ca 2+ ionophore A23187 is able to induce formation of LXA 4 (22) ; however, the enzymes involved in 15-HETE liberation or hydrolysis from phospholipid precursors have not been elucidated. We found that RAW cells also rapidly incorporate exogenous 15-HETE into phospholipids, and levels decreased 10-fold in the presence of ATP with a concomitant increase in esterified 5-HETE levels (Fig. 3C) . ATPstimulated hydrolysis of esterified 15-HETE was completely abolished with pyrrophenone, but was unaffected by the group (G)IIA, V, and X sPLA 2 inhibitor, LY315920 (varespladib). We additionally confirmed that a third macrophage phenotype, primary bone-marrow-derived macrophages (BMDMs), also produced lipoxins with TLR4 priming and 2 mM ATP (Fig. 3D) . Genetic deletion of GIVA cPLA 2 abolished lipoxin production (Fig. 3D) , 15-HETE incorporation into phospholipids after TLR4 priming, and subsequent release of 15-HETE after ATP stimulation (Fig. 3E) . 
Discussion
We have demonstrated here that 15-HETE generated by native and aspirin-acetylated COX-2 participates in classic membrane remodeling through which it is efficiently coupled to the cPLA 2 -FLAP-5-LOX pathway in parallel to AA during key inflammatory receptor stimulations (Fig. 4) . Part of this mechanism elucidates the endogenous enzymatic efficiency by which lipoxin synthesis occurs in the established two-cell systems via transcellular metabolism, as well as in single-cell systems. Because FLAP and Ca 2+ -activated 5-LOX are primarily localized at the perinuclear membrane (23), release of AA by cPLA 2 at this site is crucial for leukotriene synthesis, and 15-HETE conversion to lipoxins through FLAP and 5-LOX is under spatial and temporal constraints. The potential for cellular cPLA 2 to hydrolyze 15-HETE was previously negated based on in vitro studies where activity was only observed when 15-HETE comprised 5 mol% or less in phospholipid vesicles (24) . This observation is actually supportive, because 15-HETE levels measured in phospholipids after KLA stimulation (Fig. 2C) or with exogenous 15-HETE (Fig. 3C) were over 100-fold lower than AA levels we have previously measured (25) , not counting the high levels of other fatty acids present in cells. Most interestingly, macrophages more efficiently convert esterified 15-HETE to lipoxins via priming vs. exogenous/transcellular routes ( Fig. S7 A and B) , which we propose is due to colocalization of COX-2, FLAP, and 5-LOX at the perinuclear membrane along with cPLA 2 . A phospholipase that is largely expressed in dendritic cells, group IID sPLA 2 , has also recently been found to contribute to proresolution mediator synthesis as well as the resolution of skin inflammation (26) . Thus, coordination between different PLA 2 isoforms may also be required to facilitate maximal proresolution mediator synthesis in physiological contexts.
Increased PGE 2 derived from up-regulated COX-2 during inflammation is the primary target of nonsteroidal anti-inflammatory drugs (NSAIDs) to treat arthritis and many other inflammatory conditions because of the strong association between PGE 2 receptor EP signaling and pain, yet EP signaling also attenuates TNF-α expression and up-regulates IL-10 in macrophages (27) and can increase lipoxin production in vivo during inflammation (15) . Omega-3 fatty acids and aspirin more strongly inhibit COX-1 vs. COX-2 to promote cardioprotective actions and also partly avoid the aforementioned proinflammatory effects of COX-2 inhibitors. Still, the results presented herein suggest that therapeutic strategies should also be directed to the membrane where eicosanoids can be conditionally introduced into membrane remodeling cycles that have important implications in inflammation. Although eicosanoids have been exhaustively studied as secreted mediators, we anticipate that the complete elucidation of the fates and functions of eicosanoids in membranes will uncover new strategies for controlling proand anti-inflammatory signaling.
Materials and Methods
Methods used for cell stimulation and quantitation (6) , eicosanoid analysis (28, 29) , transcript quantitation, primary macrophage isolation/ex vivo culture (10) , and phospholipid extraction/saponification (25) were all described in previous papers, which also established appropriate sample sizes used in this study. RAW264.7 cells were obtained from the American Type Culture Collection (cat. no. TIB-71). Full protocols are described in SI Materials and Methods.
Animals. Male, 10-wk-old, C57bl/6 mice were purchased from The Jackson Laboratory. Mice exhibiting skin lesions or visible tumors were excluded from the study. All experiments were carried out according to protocols approved by the Institutional Animal Care Committee of the University of California, San Diego.
Statistical Analysis. Statistical analyses were performed using Student t test; P ≤ 0.05 was considered significant. The majority of AA oxygenated by up-regulated COX-2 forms PGH 2 (∼90-93%; via the cyclooxygenase and peroxidase active sites) and ∼4-6% is converted to 11-HETE (via the cyclooxygenase active site), and a smaller portion (∼1-3%) is converted to 15-HETE (∼30% R, ∼70% S; via the peroxidase active site). The 15-HETE is secreted from the cell, but a portion is esterified within membrane phospholipids through several possible routes putatively via fatty acyl CoA ligase. (B) Concomitantly, extracellular millimolar ATP generated by necrotized cells, PAMP recognizing cells, and recruited/activated neutrophils (reviewed in ref. 1) during a pathogenic/inflammatory assault stimulates the P2X 7 receptor in macrophages. This leads to an increase in macrophage intracellular Ca 2+ , activating cPLA 2 and 5-LOX via translocation primarily to the perinuclear membrane. LTA 4 and derived metabolites, along with 5-HETE, are produced by cPLA 2 -mediated AA hydrolysis, assistance of FLAP, and 5-LOX metabolism. Some 5-HETE becomes esterified in cell membranes (depicted in perinuclear phospholipids but potentially in other organelles as well); the rest diffuses from the cell. Esterified 15-HETE is also hydrolyzed by cPLA 2 , and a portion is then converted to LXA 4 and 15-epi-LXA 4 ; hydrolysis of 15-HETE is required to enhance metabolism by 5-LOX via coupling with cPLA 2 and FLAP. (C) In the presence of aspirin, acetylated COX-2 produces ∼100% 15(R)-HETE (and at significantly higher levels than with native enzyme). (D) Esterified 15(R)-HETE is subsequently released and converted to 15-epi-LXA 4 at enhanced levels after P2X 7 stimulation.
